Sandisk is down almost $12 premarket because of lower sales guidance. Perhaps part of that guidance could be because of the injunction imposed on it and Diablo resulting from NLST's lawsuit.
This sell off has gotten well beyond the ridiculous. I chose not to blink during this seemingly never- ending downturn and now I'm looking, like you, at a 40-point plummet. And apparently with more to come. My rationale is that the biotech sector has been so amazingly strong for me -- particularly TTPH and PTX, both of which have more than quad-tripled -- that I could afford to take a patient approach with NOV.
Now I'm getting very impatient. NOV's credentials in the oil services field represent quality and, seemingly, staying power. So I'm still trying to cling to the notion that when this turns, NOV will be one of the prime beneficiaries. Comments?
It appears you've earned the right to crow a little after ADXS' distinctive move Friday in a sea of red market. Good luck.
Your messages appear less like the playful banter of a proven investing veteran and more like the drivel of a sick puppy who is confusing your possible success in one or two stocks with an investing acumen that will have staying power. Like Miss Kitty has.
Sudnwealth, to use a sports analogy when one is describing a great athlete being compared to one of obviously less proven skill, you might say, "You couldn't carry her jock." Or perhaps in this case, her panties.
Miss Kitty has achieved near legendary status on a number of biotech boards and doesn't need to prove anything to anybody any more. You? Who knows? Perhaps you have some greatness in you, but you come off like a youngish boxer trying to goat the champion into a fight, mainly because your ego exceeds your resume.
AKAO is on sale right now. It will rise again.
A little harsh, dogginit. Aside from the fact that his hair looked as if he just walked out of a wind tunnel, he spoke with a deep, clear voice and was quite lucid in his remarks. If you were looking for him to put on an animated display about Tetraphase's greatness, a little premature. That would only trigger thoughts of an around-the-world cruise from an avalanche of vulture lawyers, in the long shot case something should go awry. So he did the smart thing, and just gave people an inkling of what could lie ahead.
EXC appears to be giving away the "farm" in these agreements with the various and sundry public service commissions, but don't be deceived: there is a huge pot of gold at the end of this gauntlet.
Two more approvals and the good times will roll.
However, curiously BCE rose $1.17 from Jan. 28-Feb. 5, then suddenly plunges $2.12 the next day. -- the same day it's downgraded. Maybe that was just coincidence, but I doubt it.